NxStage

NxStage Medical, Inc.

Company type	Division
Industry	Medical devices
Founded	December 1998 (1998-12)
Founder	C. David Finch, Jr., Jeffrey H. Burbank
Headquarters	Lawrence, Massachusetts , United States
Area served	Worldwide
Products	System One (hemodialysis machine)
Parent	Fresenius Medical Care

NxStage Medical, Inc. () is an American enterprise focused on designing, producing, and distributing devices for managing chronic kidney disease, acute kidney injury, and hypervolemia. It functions as a division of Fresenius Medical Care. The company's primary offering is System One, a compact hemodialysis machine.

History

Established in December 1998 by C. David Finch, Jr., MD, alongside Jeffrey H. Burbank, NxStage introduced System One in 2003 with an emphasis on the critical care sector. The device gained Food and Drug Administration approval for home hemodialysis use in June 2005.

The firm became publicly traded through an initial public offering in October 2005. Soon after, it was honored with the Nixon Peabody/Smith&Nephew Medical Device Innovation Award in the Start-Up category from the Massachusetts Medical Device Industry Council.

In December 2014, NxStage received FDA authorization for overnight home usage of System One. The company further broadened its reach by obtaining FDA clearance in August 2017 to enable solo home hemodialysis during daytime hours without requiring a care partner.

In February 2019, Fresenius Medical Care acquired NxStage for $2 billion, incorporating its portable dialysis solutions into Fresenius's extensive renal care offerings.